Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 8Active not recruiting 5Recruiting 3Withdrawn 2Unknown 2Terminated 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 6Genitourinary 5Gastrointestinal 3Gynecologic 2Thoracic 1Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 5Lymphatic Metastasis 1Encopresis 1

Interventions

pembrolizumab 65Nivolumab 58Magnetic Resonance Spectroscopy 53enzalutamide 39Abiraterone Acetate 37Radiosurgery 36Gemcitabine 35Specimen Handling 32Radiotherapy 32Ipilimumab 32Androgen Antagonists 32Prednisone 31apalutamide 28Cisplatin 28Docetaxel 27Leuprolide 26atezolizumab 25Carboplatin 25durvalumab 23cabozantinib 23darolutamide 20acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 19olaparib 18Goserelin 17Radiation 16Gonadotropin-Releasing Hormone 16Biopsy 16gallium 68 PSMA-11 15Pluvicto 15avelumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Radiation Dose Hypofractionation × Genitourinary × Clear all
NCT03987386 2026-05-20

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
186 enrolled
Genitourinary

Prostatic Neoplasms

NCT04262609 2026-03-19

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Consorci Sanitari de Terrassa

Active not recruiting
200 enrolled
Genitourinary

Encopresis, Prostatic Neoplasms

NCT04624256 2026-03-13

GARUDA

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
208 enrolled
Genitourinary

Prostatic Neoplasms

NCT03796767 2026-01-28

SOAR

University of Utah

Phase 2 Active not recruiting
20 enrolled 26 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

NCT01444820 2024-12-04

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Sir Mortimer B. Davis - Jewish General Hospital

Phase 3 Active not recruiting
329 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡